110824 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus; Methods of inactivation or attenuation by genetic engineering
INFLUENZA VIRUS VACCINES AND USES THEREOF
#2DEOPTIMIZED INFLUENZA VIRUSES AND METHODS OF TREATING CANCER
#3INFLUENZA VIRUS MUTANTS AND USES THEREFOR
#4ATTENUATED ORTHOMYXOVIRUS-BASED VECTOR PLATFORM
#5PARENTERALLY ADMINISTRABLE INFLUENZA VACCINE AND USES THEREOF
#6ATTENUATION METHOD OF INFLUENZA VIRUS, ATTENUATED INFLUENZA VIRUS STRAIN, AND USE THEREOF
#7RECOMBINANT VIRUS CONTAINING DEGRON, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#8ATTENUATED VIRUSES USEFUL FOR VACCINES
#9ATTENUATED INFLUENZA VIRUSES AND VACCINES
#10Hemagglutinin Modifications for Improved Influenza Vaccine Production
#11Modulation of replicative fitness by deoptimization of synonymous codons
#12Influenza virus mutants and uses therefor
#13VIRAL MEDIATED GENE DELIVERY FOR TRANSIENT EXPRESSION OF PROTEINS
#14ASSAY AND MEDICAMENT
#15PROTEOLYSIS-TARGETING VIRUS, LIVE VACCINE THEREOF, PREPARATION METHOD AND USE THEREOF
#16Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#17Recombinant influenza viruses and constructs and uses thereof
#18Recombinant H7N9 subtype avian influenza virus, inactivated marked vaccine and preparation method thereof
#19Attenuated influenza viruses and vaccines
#20REPLICATION-LIMITED MUCOSAL IMMUNE VACCINE FOR INFLUENZA VIRUS
#21Mutant virus, preparation method therefor and application thereof
#22Modulation of replicative fitness by deoptimization of synonymous codons
#23Assay and medicament
#24Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#25Genome-wide identification of immune evasion functions in a virus
#26Influenza virus mutants and uses therefor
#27Equine influenza virus live attenuated vaccines
#28Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery
#29Influenza virus mutants and uses therefor
#30Influenza virus vector for virotherapy
#31Attenuated viruses useful for vaccines
#32Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#33Modulation of replicative fitness by deoptimization of synonymous codons
#34Recombinant Influenza Virus
#35Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases
#36Attenuated influenza vaccines and uses thereof
#37Methods of making and using live attenuated viruses
#38RNA virus attenuation by alteration of mutational robustness and sequence space
#39MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS
#40Dual purpose universal influenza vaccine confers protective immunity against anthrax
#41Recombinant swine influenza virus and uses thereof
#42Methods of making modified viral genomes
#43Live-attenuated virus and methods of production and use
#44ASSAY AND MEDICAMENT
#45ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#46Influenza virus vector for virotherapy
#47Influenza virus mutants and uses therefor
#48Influenza virus mutants and uses therefor
#49Live attenuated vaccines for influenza viruses
#50Attenuated influenza viruses and vaccines
#51Influenza virus vaccines and uses thereof
#52Deletion mutants of flagellin and methods of use
#53Deletion mutants of flagellin and methods of use
#54Composition
#55Recombinant influenza viruses and constructs and uses thereof
#56Multi plasmid system for the production of influenza virus
#57Influenza virus mutants and uses therefor
#58Multi plasmid system for the production of influenza virus
#59Multi plasmid system for the production of influenza virus
#60ATTENUATED INFLUENZA VIRUSES AND VACCINES
#61Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#62Influenza viruses and uses thereof
#63Multi plasmids system for the production of influenza virus
#64Method of preparing live viral vaccines by genetic engineering of viral genome
#65INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#66Multi plasmid system for the production of influenza virus
#67Anti-viral protection with viruses containing defective genome segments
#68Influenza hemagglutinin and neuraminidase variants
#69Deletion mutants of flagellin and methods of use
#70Influenza A virus with attenuating mutations in NS2 protein
#71Influenza hemagglutinin and neuraminidase variants
#72Influenza A virus vaccines and inhibitors
#73NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#74Attenuated viruses useful for vaccines
#75ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#76Neuraminidase-deficient live influenza vaccines
#77Multi plasmid system for the production of influenza virus
#78Methods for the propagation of modified influenza viruses in embryonated eggs
#79Influenza hemagglutinin and neuraminidase variants
#80Method for producing temperature sensitive influenza A viruses
#81Attenuated RNA virus and applications thereof
#82Influenza hemagglutinin and neuraminidase variants
#83Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#84Canine influenza virus and related compositions and methods of use
#85Defective Influenza Virus Particles
#86Modulation of replicative fitness by deoptimization of synonymous codons
#87Influenza A virus vaccines and inhibitors
#88Canine influenza virus and related compositions and methods of use
#89Influenza hemagglutinin and neuraminidase variants
#90Influenza hemagglutinin and neuraminidase variants
#91Multi plasmid system for the production of influenza virus
#92Multi plasmid system for the production of influenza virus
#93Methods and interferon deficient substrates for the propagation of viruses